Loading…
Loading…
Lake Oswego, Oregon--(Newsfile Corp. - April 29, 2026) - Functional Brands Inc. (NASDAQ: MEHA), a leading innovator in wellness and performance products, today announced a significant expansion of its digital health platform, www.Tru2u.health, with the addition of NAD+ (Nicotinamide Adenine Dinucleotide) therapy. This milestone enhances Tru2u.health's already comprehensive suite of solutions that includes peptide protocols, GLP-1-based weight management, and board-certified telehealth support.
Municipal bonds offer tax-exempt income with lower default risk than similarly rated corporate bonds, making them attractive for higher-income investors. Long-duration munis are well-positioned to benefit from a potential decline in long-term interest rates. Closed-end funds provide diversified exposure but vary meaningfully in leverage, credit risk, distribution strategy, and discounts to NAV.
Nuveen Quality Municipal Income Fund (NYSE: NAD - Get Free Report)'s share price passed below its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $11.96 and traded as low as $11.81. Nuveen Quality Municipal Income Fund shares last traded at $11.8850, with a volume of 372,158 shares. Nuveen
Nuveen Quality Municipal Income Fund (NAD) and Nuveen AMT-Free Quality Municipal Income Fund (NEA) are nearly identical municipal bond CEFs with highly correlated NAVs. Currently, NEA trades at a 120 basis point tighter discount than NAD, compared to the average discount values. This creates a mispricing opportunity for a pair trade. Historical NAV correlation (99.7%) and mean reversion patterns suggest NAD is undervalued by $0.14–$0.15 relative to NEA.
Shares of Nuveen Quality Municipal Income Fund (NYSE: NAD - Get Free Report) passed below its two hundred day moving average during trading on Friday. The stock has a two hundred day moving average of $11.96 and traded as low as $11.11. Nuveen Quality Municipal Income Fund shares last traded at $11.2780, with a volume
Nuveen Quality Municipal Income Fund invests in high-grade municipal bonds, aiming to deliver federally tax-exempt income for shareholders.
LOS ANGELES--(BUSINESS WIRE)---- $NAGE #ClinicalResearch--Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announces it is the headlining sponsor of the inaugural NAD for Health: Opportunities & Challenges scientific meeting hosted by the University of Copenhagen, taking place March 23–25, 2026 at the Royal Danish Academy of Sciences and Letters in central Copenhagen. Space is limited and registration is require.
LOS ANGELES--(BUSINESS WIRE)---- $NAGE #Biotech--Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announces that it has partnered with Truemed to provide qualified customers the option to purchase Tru Niagen®, the number one NAD+ supplement in the United States*, using Health Savings Account (HSA) and Flexible Spending Account (FSA) funds on its direct-to-consumer website, www.truniagen.com. Qualified custo.